Objective:Resveratrol shows chemopreventive activity in a variety of human cancers by targeting mitochondria and triggering apoptosis.
The purpose of this study was to investigate the antitumor action of resveratrol in bladder cancer and its underlying mechanism.
Methods:Using two different bladder cell lines, BTT739 and T24, the cytotoxicity of resveratrol were determined by MTT assay. The apoptosis induced by resveratrol was assayed by transferase dUTP nick end labeling staining. To show whether the mitochondrial dysfunction involved in the effects of resveratrol, mitochondrial function was detected by mitochondrial membrane potential, reactive oxygen species production and adenosine 5'-triphosphate content. In addition, the markers of apoptosis in the intrinsic mitochondrial-dependent pathway were analyzed by the release of cytochrome c and the activities of caspase-9 and caspase-3.
Results:Resveratrol effectively decreased cell viability and induced apoptosis in a concentration- and time-dependent manner. In addition, resveratrol significantly disrupted the mitochondrial membrane potential in both intact cells and isolated mitochondria. Resveratrol also increased reactive oxygen species production and reduced adenosine 5'-triphosphate concentrations. Western blot analysis showed that resveratrol provoked the release of cytochrome c from mitochondria to the cytosol. Furthermore, resveratrol significantly promoted the activation of caspase-9 and caspase-3.
Conclusions:These findings suggest that resveratrol efficiently triggers apoptosis in bladder cancer cells through the intrinsic mitochondrial-dependent pathway, which is associated with mitochondrial dysfunction. Resveratrol might have great pharmacological promise in the treatment of bladder cancer.
Written by:
Lin X, Wu G, Huo WQ, Zhang Y, Jin FS. Are you the author?
Department of Urology, Daping Hospital, The Third Military Medical University, Chongqing, China.
Reference: Int J Urol. 2012 Aug;19(8):757-64.
doi: 10.1111/j.1442-2042.2012.03024.x
PubMed Abstract
PMID: 22607368
UroToday.com Investigative Urology Section
